XBiotech Inc.
XBIT
$2.27
-$0.04-1.73%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -26.89M | -6.01M | -1.76M | -10.88M | -10.51M |
| Total Depreciation and Amortization | 378.00K | 427.00K | 439.00K | 442.00K | 439.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -1.00M | 1.23M | -2.97M | 3.05M | 4.73M |
| Change in Net Operating Assets | 4.57M | 96.00K | -1.70M | 677.00K | -1.20M |
| Cash from Operations | -22.95M | -4.26M | -5.99M | -6.72M | -6.54M |
| Capital Expenditure | -34.00K | -110.00K | -51.00K | -94.00K | -84.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -34.00K | -110.00K | -51.00K | -94.00K | -84.00K |
| Total Debt Issued | -- | -- | -- | -- | 250.00K |
| Total Debt Repaid | 0.00 | 0.00 | 0.00 | -10.25M | -- |
| Issuance of Common Stock | -- | -- | -- | -- | 33.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 0.00 | 0.00 | 0.00 | -10.25M | 283.00K |
| Foreign Exchange rate Adjustments | 1.17M | -1.20M | 3.08M | 284.00K | -4.10M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -21.82M | -5.57M | -2.96M | -16.78M | -10.44M |